ASCO 2026: PSMAddition shows 177Lu-PSMA-617 boosts rPFS across mHSPC subgroups, with steady safety and insights on PSMA PET ...
Andrew L. Pecora, MD, discusses the significance of the long-term findings from the KEYNOTE-942 trial of intismeran autogene ...
Dr McDonald shares promising data linking GLP-1 use to lower breast cancer risk, highlighting the need for clinical trials to ...
Abemaciclib (Verzenio) reduced the risk of progression or death by 62% compared with placebo in patients with advanced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results